About Phibro Animal Health (NASDAQ:PAHC)
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Israel, Latin America, Canada, Europe, Africa, and the Asia/Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation is headquartered in Teaneck, New Jersey.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300
Debt
Debt-to-Equity Ratio1.82%
Current Ratio3.12%
Quick Ratio1.75%
Price-To-Earnings
Trailing P/E Ratio29.14
Forward P/E Ratio25.56
P/E Growth3.12
Sales & Book Value
Annual Sales$764.30 million
Price / Sales2.27
Cash Flow$2.1546 per share
Price / Cash20.05
Book Value$3.79 per share
Price / Book11.40
Profitability
EPS (Most Recent Fiscal Year)$1.51
Net Income$64.61 million
Net Margins7.90%
Return on Equity40.49%
Return on Assets9.94%
Miscellaneous
Employees1,400
Outstanding Shares40,190,000
Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions
What is Phibro Animal Health's stock symbol?
Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."
How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?
Phibro Animal Health announced a quarterly dividend on Tuesday, February 6th. Investors of record on Wednesday, March 7th will be given a dividend of $0.10 per share on Wednesday, March 28th. This represents a $0.40 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date of this dividend is Tuesday, March 6th. View Phibro Animal Health's Dividend History.
How were Phibro Animal Health's earnings last quarter?
Phibro Animal Health (NASDAQ:PAHC) issued its quarterly earnings data on Monday, February, 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.06. The business earned $205.90 million during the quarter, compared to the consensus estimate of $194.90 million. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The firm's revenue was up 7.5% on a year-over-year basis. During the same period last year, the business posted $0.39 earnings per share. View Phibro Animal Health's Earnings History.
When is Phibro Animal Health's next earnings date?
What guidance has Phibro Animal Health issued on next quarter's earnings?
Phibro Animal Health issued an update on its FY18 earnings guidance on Monday, February, 5th. The company provided earnings per share (EPS) guidance of $1.65-1.72 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.56. The company issued revenue guidance of $800-825 million, compared to the consensus revenue estimate of $783.58 million.
What price target have analysts set for PAHC?
4 brokers have issued twelve-month price targets for Phibro Animal Health's shares. Their forecasts range from $33.00 to $42.00. On average, they expect Phibro Animal Health's stock price to reach $37.50 in the next twelve months. View Analyst Ratings for Phibro Animal Health.
Who are some of Phibro Animal Health's key competitors?
Some companies that are related to Phibro Animal Health include Array BioPharma (ARRY), Tesaro (TSRO), Ultragenyx Pharmaceutical (RARE), Emergent BioSolutions (EBS), Amicus Therapeutics (FOLD), Ascendis Pharma (ASND), Evotec A.G. (EVTCY), Clovis Oncology (CLVS), Ironwood Pharmaceuticals (IRWD), Supernus Pharmaceuticals (SUPN), Acadia Pharmaceuticals (ACAD), Akorn (AKRX), Puma Biotechnology (PBYI), Horizon Pharma (HZNP), Heron Therapeutics (HRTX), Global Blood Therapeutics (GBT), Portola Pharmaceuticals (PTLA) and AnaptysBio (ANAB).
Who are Phibro Animal Health's key executives?
Phibro Animal Health's management team includes the folowing people:
- Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 71)
- Mr. Larry L. Miller, Chief Operating Officer (Age 54)
- Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 49)
- Mr. Richard G. Johnson, Chief Financial Officer (Age 69)
- Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 60)
Has Phibro Animal Health been receiving favorable news coverage?
Media stories about PAHC stock have been trending somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Phibro Animal Health earned a coverage optimism score of 0.09 on Accern's scale. They also gave news stories about the company an impact score of 46.32 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Phibro Animal Health?
Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Phibro Animal Health's stock price today?
One share of PAHC stock can currently be purchased for approximately $43.25.
How big of a company is Phibro Animal Health?
Phibro Animal Health has a market capitalization of $1.77 billion and generates $764.30 million in revenue each year. The company earns $64.61 million in net income (profit) each year or $1.51 on an earnings per share basis. Phibro Animal Health employs 1,400 workers across the globe.
How can I contact Phibro Animal Health?
Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]
MarketBeat Community Rating for Phibro Animal Health (PAHC)
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Phibro Animal Health (NASDAQ:PAHC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Phibro Animal Health in the last 12 months. Their average twelve-month price target is $37.50, suggesting that the stock has a possible downside of 13.19%. The high price target for PAHC is $42.00 and the low price target for PAHC is $33.00. There are currently 2 sell ratings, 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 1.75 | 1.75 | 2.33 | 2.00 |
| Ratings Breakdown: | 2 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $37.50 | $37.50 | $37.3333 | $33.00 |
| Price Target Upside: | 13.19% downside | 2.46% upside | 7.90% upside | 11.76% downside |
Phibro Animal Health (NASDAQ:PAHC) Consensus Price Target History
Phibro Animal Health (NASDAQ:PAHC) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 2/7/2018 | Morgan Stanley | Boost Price Target | Underweight -> Underweight | $30.00 -> $36.00 | Low |  |
| 2/6/2018 | Credit Suisse Group | Boost Price Target | Neutral -> Neutral | $37.00 -> $39.00 | Medium | |
| 11/10/2017 | Piper Jaffray | Reiterated Rating | Buy | $42.00 | N/A | |
| 8/23/2017 | Bank of America | Reiterated Rating | Underperform -> Underperform | $33.00 | High | |
| 11/11/2016 | Macquarie | Downgrade | Neutral -> Underperform | $21.00 | N/A | |
| 11/10/2016 | Gabelli | Downgrade | Buy -> Hold | | N/A | |
| 9/12/2016 | Guggenheim | Set Price Target | Buy | $26.00 -> $30.00 | N/A | |
(Data available from 4/23/2016 forward)
Phibro Animal Health (NASDAQ:PAHC) Dividend Information
Phibro Animal Health pays an annual dividend of $0.40 per share, with a dividend yield of 0.93%. PAHC's most recent quarterly dividend payment was Wednesday, March 28. Phibro Animal Health pays out 26.49% of its earnings out as a dividend.
| Most Recent Dividend: | 3/28/2018 |
| Annual Dividend: | $0.40 |
| Dividend Yield: | 0.93% |
| Payout Ratio: | 26.49% (Trailing 12 Months of Earnings)
23.67% (Based on This Year's Estimates)
21.39% (Based on Next Year's Estimates)
|
Phibro Animal Health (NASDAQ:PAHC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/6/2018 | quarterly | $0.10 | 1.1% | 3/6/2018 | 3/7/2018 | 3/28/2018 |
| 11/7/2017 | quarterly | $0.10 | 1.12% | 12/5/2017 | 12/6/2017 | 12/27/2017 |
| 7/25/2017 | quarterly | $0.10 | 1.04% | 9/1/2017 | 9/6/2017 | 9/27/2017 |
| 5/9/2017 | Quarterly | $0.10 | 1.2% | 5/26/2017 | 5/31/2017 | 6/22/2017 |
| 2/7/2017 | quarterly | $0.10 | 1.37% | 2/27/2017 | 3/1/2017 | 3/22/2017 |
| 11/8/2016 | quarterly | $0.10 | 1.51% | 11/28/2016 | 11/30/2016 | 12/21/2016 |
| 7/26/2016 | quarterly | $0.10 | 1.95% | 9/2/2016 | 9/7/2016 | 9/28/2016 |
| 5/10/2016 | quarterly | $0.10 | 2.17% | 5/27/2016 | 6/1/2016 | 6/22/2016 |
| 2/9/2016 | quarterly | $0.10 | 1.18% | 2/29/2016 | 3/2/2016 | 3/23/2016 |
| 11/10/2015 | quarterly | $0.10 | 1.26% | 11/30/2015 | 12/2/2015 | 12/23/2015 |
| 7/28/2015 | quarterly | $0.10 | 1.08% | 8/31/2015 | 9/2/2015 | 9/23/2015 |
| 5/12/2015 | quarterly | $0.10 | 1.09% | 6/1/2015 | 6/3/2015 | 6/24/2015 |
| 2/10/2015 | quarterly | $0.10 | 1.43% | 3/2/2015 | 3/4/2015 | 3/25/2015 |
| 11/10/2014 | quarterly | $0.10 | 1.43% | 12/1/2014 | 12/3/2014 | 12/23/2014 |
| 7/28/2014 | quarterly | $0.10 | | 8/29/2014 | 9/3/2014 | 9/24/2014 |
(Data available from 1/1/2013 forward)
Phibro Animal Health (NASDAQ PAHC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 51.88%
Institutional Ownership Percentage: 48.14%
Phibro Animal Health (NASDAQ PAHC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/15/2018 | Jack Bendheim | Insider | Sell | 24,000 | $40.05 | $961,200.00 | | |
| 3/14/2018 | Bfi Co., Llc | Major Shareholder | Sell | 12,000 | $40.12 | $481,440.00 | 24,000 | |
| 3/12/2018 | Daniel M Bendheim | VP | Sell | 13,162 | $40.00 | $526,480.00 | 3,425 | |
| 3/9/2018 | Daniel M Bendheim | VP | Sell | 6,576 | $40.03 | $263,237.28 | 3,425 | |
| 3/7/2018 | Bfi Co., Llc | Major Shareholder | Sell | 12,000 | $38.92 | $467,040.00 | 72,000 | |
| 3/7/2018 | Jack Bendheim | Insider | Sell | 36,000 | $39.01 | $1,404,360.00 | | |
| 3/6/2018 | Daniel M Bendheim | VP | Sell | 3,960 | $40.06 | $158,637.60 | 3,860 | |
| 3/5/2018 | Bfi Co., Llc | Major Shareholder | Sell | 12,000 | $39.35 | $472,200.00 | 72,000 | |
| 3/1/2018 | Bfi Co., Llc | Major Shareholder | Sell | 12,000 | $38.20 | $458,400.00 | 72,000 | |
| 3/1/2018 | Jack Bendheim | Insider | Sell | 36,000 | $38.35 | $1,380,600.00 | | |
| 2/27/2018 | Jack Bendheim | CEO | Sell | 12,000 | $38.44 | $461,280.00 | 72,000 | |
| 2/23/2018 | Bfi Co., Llc | Major Shareholder | Sell | 14,802 | $38.15 | $564,696.30 | 33,198 | |
| 2/22/2018 | Jack Bendheim | CEO | Sell | 2,802 | $38.01 | $106,504.02 | | |
| 2/13/2018 | Larry Lee Miller | COO | Sell | 54,572 | $35.36 | $1,929,665.92 | 8,582 | |
| 2/9/2018 | Dean J Warras | Insider | Sell | 10,000 | $35.62 | $356,200.00 | 10,000 | |
| 2/9/2018 | Larry Lee Miller | COO | Sell | 14,182 | $35.49 | $503,319.18 | 8,582 | |
| 9/15/2017 | Dean J Warras | Insider | Sell | 10,000 | $35.70 | $357,000.00 | 10,000 | |
| 9/14/2017 | Larry Lee Miller | COO | Sell | 21,439 | $36.43 | $781,022.77 | 15,891 | |
| 9/14/2017 | Richard G Johnson | CFO | Sell | 55,529 | $36.30 | $2,015,702.70 | 15,900 | |
| 9/13/2017 | Larry Lee Miller | COO | Sell | 15,891 | $36.46 | $579,385.86 | 15,891 | |
| 9/13/2017 | Richard G Johnson | CFO | Sell | 15,900 | $36.46 | $579,714.00 | 15,900 | |
| 9/12/2017 | Larry Lee Miller | COO | Sell | 46,102 | $36.33 | $1,674,885.66 | 14,930 | |
| 9/12/2017 | Richard G Johnson | CFO | Sell | 47,264 | $36.32 | $1,716,628.48 | 14,623 | |
| 9/11/2017 | Gerald K Carlson | Director | Sell | 5,400 | $36.27 | $195,858.00 | 5,400 | |
| 9/7/2017 | Larry Lee Miller | COO | Sell | 32,459 | $35.59 | $1,155,215.81 | 4,237 | |
| 9/7/2017 | Richard G Johnson | CFO | Sell | 29,807 | $35.66 | $1,062,917.62 | 4,240 | |
| 8/21/2017 | Daniel M Bendheim | VP | Sell | 4,976 | $40.01 | $199,089.76 | 4,176 | |
| 8/16/2017 | Daniel M Bendheim | VP | Sell | 5,938 | $40.04 | $237,757.52 | 300 | |
| 8/15/2017 | Daniel M Bendheim | VP | Sell | 1,443 | $40.05 | $57,792.15 | 300 | |
| 8/14/2017 | Daniel M Bendheim | VP | Sell | 300 | $40.08 | $12,024.00 | 300 | |
| 7/6/2017 | Bfi Co., Llc | Major Shareholder | Sell | 16,000 | $36.00 | $576,000.00 | 28,000 | |
| 7/6/2017 | Jack Bendheim | Insider | Sell | 32,000 | $36.49 | $1,167,680.00 | | |
| 7/5/2017 | Bfi Co., Llc | Major Shareholder | Sell | 16,000 | $36.98 | $591,680.00 | 28,000 | |
| 6/30/2017 | Bfi Co., Llc | Major Shareholder | Sell | 48,000 | $37.42 | $1,796,160.00 | 92,000 | |
| 6/23/2017 | Jack Bendheim | Insider | Sell | 48,000 | $37.15 | $1,783,200.00 | | |
| 6/15/2017 | Bfi Co., Llc | Major Shareholder | Sell | 48,000 | $34.82 | $1,671,360.00 | 96,000 | |
| 6/9/2017 | Jack Bendheim | Insider | Sell | 48,000 | $35.62 | $1,709,760.00 | | |
| 5/25/2017 | Jack Bendheim | Insider | Sell | 48,000 | $34.67 | $1,664,160.00 | | |
| 5/19/2017 | Jack Bendheim | Insider | Sell | 48,000 | $34.15 | $1,639,200.00 | | |
| 5/11/2017 | Gerald K Carlson | Director | Sell | 63,338 | $33.31 | $2,109,788.78 | 50 | |
| 5/10/2017 | Jack Bendheim | Insider | Sell | 1,400 | $34.04 | $47,656.00 | | |
| 5/9/2017 | Larry Lee Miller | COO | Sell | 56,825 | $30.95 | $1,758,733.75 | 20,836 | |
| 5/9/2017 | Thomas G Dagger | SVP | Sell | 8,000 | $32.13 | $257,040.00 | 8,000 | |
| 5/4/2017 | Larry Lee Miller | COO | Sell | 18,953 | $30.13 | $571,053.89 | 11,969 | |
| 5/1/2017 | Larry Lee Miller | COO | Sell | 14,780 | $30.13 | $445,321.40 | 4,397 | |
| 3/20/2017 | Gerald K Carlson | Director | Sell | 12,000 | $28.13 | $337,560.00 | 12,000 | |
| 2/27/2017 | Gerald K Carlson | Director | Sell | 12,000 | $28.29 | $339,480.00 | 12,000 | |
| 2/16/2017 | Daniel A Welch | SVP | Sell | 5,000 | $29.55 | $147,750.00 | 5,000 | |
| 2/16/2017 | Larry Lee Miller | COO | Sell | 4,588 | $30.00 | $137,640.00 | 3,281 | |
| 2/15/2017 | Gerald K Carlson | Director | Sell | 12,000 | $29.77 | $357,240.00 | 12,000 | |
| 2/13/2017 | Larry Lee Miller | COO | Sell | 97,229 | $30.37 | $2,952,844.73 | 29,562 | |
| 1/4/2017 | Thomas G Dagger | SVP | Sell | 207 | $30.00 | $6,210.00 | 200 | |
| 1/3/2017 | Larry Lee Miller | COO | Sell | 187 | $30.00 | $5,610.00 | 187 | |
| 12/20/2016 | Larry Lee Miller | COO | Sell | 1,540 | $30.04 | $46,261.60 | 252 | |
| 12/20/2016 | Thomas G Dagger | SVP | Sell | 1,700 | $30.03 | $51,051.00 | 200 | |
| 12/19/2016 | Larry Lee Miller | COO | Sell | 252 | $30.00 | $7,560.00 | 252 | |
| 12/19/2016 | Thomas G Dagger | SVP | Sell | 200 | $30.01 | $6,002.00 | 200 | |
| 5/19/2016 | E Thomas Corcoran | Director | Buy | 5,000 | $18.14 | $90,700.00 | 10,000 | |
| 4/1/2016 | Gerald K Carlson | COO | Sell | 8,000 | $27.02 | $216,160.00 | 3,594 | |
| 2/19/2016 | Gerald K Carlson | COO | Sell | 8,000 | $28.09 | $224,720.00 | 8,000 | |
| 2/17/2016 | Bfi Co., Llc | Major Shareholder | Sell | 2,175 | $30.01 | $65,271.75 | 72,425 | |
| 2/10/2016 | Bfi Co., Llc | major shareholder | Sell | 3,400 | $30.78 | $104,652.00 | 74,600 | |
| 2/3/2016 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $33.26 | $133,040.00 | 66,000 | |
| 2/3/2016 | Jack Bendheim | CEO | Sell | 12,000 | $33.39 | $400,680.00 | | |
| 2/2/2016 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $33.44 | $133,760.00 | 66,000 | |
| 2/1/2016 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $33.46 | $133,840.00 | 66,000 | |
| 2/1/2016 | Larry Lee Miller | President | Sell | 60,000 | $33.58 | $2,014,800.00 | | |
| 1/29/2016 | Jack Bendheim | CEO | Sell | 39,944 | $32.10 | $1,282,202.40 | | |
| 1/26/2016 | Daniel A. Welch | SVP | Sell | 3,000 | $32.05 | $96,150.00 | | |
| 1/26/2016 | Gerald K. Carlson | COO | Sell | 12,923 | $32.13 | $415,215.99 | | |
| 1/22/2016 | Larry Lee Miller | President | Sell | 51,225 | $30.07 | $1,540,335.75 | | |
| 1/20/2016 | Gerald K. Carlson | COO | Sell | 8,000 | $29.27 | $234,160.00 | | |
| 1/8/2016 | Larry Lee Miller | President | Sell | 4,303 | $30.03 | $129,219.09 | | |
| 1/6/2016 | Bfi Co., Llc | major shareholder | Sell | 3,005 | $29.93 | $89,939.65 | 69,944 | |
| 1/6/2016 | Jack Bendheim | CEO | Sell | 8,056 | $30.01 | $241,760.56 | | |
| 1/6/2016 | Larry Lee Miller | President | Sell | 4,472 | $30.10 | $134,607.20 | | |
| 1/5/2016 | Bfi Co., Llc | major shareholder | Sell | 4,851 | $30.07 | $145,869.57 | 69,944 | |
| 1/4/2016 | Bfi Co., Llc | major shareholder | Sell | 200 | $29.92 | $5,984.00 | 69,944 | |
| 12/30/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $30.63 | $122,520.00 | 66,000 | |
| 12/30/2015 | Jack Bendheim | CEO | Sell | 12,000 | $30.49 | $365,880.00 | | |
| 12/29/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $30.49 | $121,960.00 | 66,000 | |
| 12/28/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $30.34 | $121,360.00 | 66,000 | |
| 12/23/2015 | Gerald K. Carlson | COO | Sell | 2,006 | $32.03 | $64,252.18 | | |
| 12/22/2015 | Gerald K. Carlson | COO | Sell | 1,071 | $32.02 | $34,293.42 | | |
| 12/21/2015 | Gerald K. Carlson | COO | Sell | 8,000 | $31.13 | $249,040.00 | | |
| 12/18/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.83 | $381,960.00 | | |
| 12/15/2015 | Larry Lee Miller | insider | Sell | 36,090 | $31.00 | $1,118,790.00 | | |
| 12/14/2015 | Larry Lee Miller | insider | Sell | 23,910 | $30.74 | $734,993.40 | | |
| 12/11/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.58 | $378,960.00 | | |
| 12/3/2015 | Jack Bendheim | CEO | Sell | 12,000 | $32.63 | $391,560.00 | | |
| 11/24/2015 | Gerald K. Carlson | COO | Sell | 16,000 | $32.08 | $513,280.00 | | |
| 11/24/2015 | Thomas G. Dagger | SVP | Sell | 4,000 | $32.87 | $131,480.00 | | |
| 11/18/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $31.68 | $126,720.00 | 66,000 | |
| 11/18/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.63 | $379,560.00 | | |
| 11/17/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $31.71 | $126,840.00 | 66,000 | |
| 11/16/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $31.50 | $126,000.00 | 66,000 | |
| 11/12/2015 | Bfi Co., Llc | major shareholder | Sell | 12,000 | $32.21 | $386,520.00 | 66,000 | |
| 11/5/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.11 | $397,320.00 | | |
| 10/30/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.21 | $398,520.00 | | |
| 10/26/2015 | Gerald K. Carlson | COO | Sell | 7,900 | $32.15 | $253,985.00 | | |
| 10/26/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.73 | $380,760.00 | | |
| 10/21/2015 | Gerald K. Carlson | COO | Sell | 8,100 | $32.40 | $262,440.00 | | |
| 10/16/2015 | Daniel A. Welch | SVP | Sell | 3,000 | $32.93 | $98,790.00 | | |
| 10/16/2015 | Jack Bendheim | CEO | Sell | 12,000 | $32.10 | $385,200.00 | | |
| 10/9/2015 | Jack Bendheim | CEO | Sell | 12,000 | $30.64 | $367,680.00 | | |
| 10/1/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.44 | $377,280.00 | | |
| 9/25/2015 | Jack Bendheim | CEO | Sell | 10,000 | $33.95 | $339,500.00 | | |
| 9/23/2015 | Thomas G. Dagger | SVP | Sell | 4,000 | $34.76 | $139,040.00 | | |
| 9/22/2015 | Gerald K. Carlson | COO | Sell | 8,000 | $34.97 | $279,760.00 | | |
| 9/21/2015 | Gerald K. Carlson | COO | Sell | 8,000 | $35.99 | $287,920.00 | | |
| 9/18/2015 | Jack Bendheim | CEO | Sell | 18,000 | $35.90 | $646,200.00 | | |
| 9/16/2015 | Dean J. Warras | insider | Sell | 4,000 | $34.73 | $138,920.00 | | |
| 9/10/2015 | Jack Bendheim | CEO | Sell | 18,000 | $34.69 | $624,420.00 | | |
| 9/3/2015 | Bfi Co., Llc | major shareholder | Sell | 16,900 | $35.08 | $592,852.00 | 67,100 | |
| 9/3/2015 | Jack Bendheim | CEO | Sell | 1,100 | $35.10 | $38,610.00 | | |
| 8/28/2015 | Jack Bendheim | CEO | Sell | 18,000 | $34.89 | $628,020.00 | | |
| 8/21/2015 | Gerald K. Carlson | COO | Sell | 16,000 | $35.04 | $560,640.00 | | |
| 8/19/2015 | Bfi Co., Llc | Major Shareholder | Sell | 6,000 | $36.91 | $221,460.00 | | |
| 8/19/2015 | Jack Bendheim | CEO | Sell | 18,000 | $37.14 | $668,520.00 | | |
| 8/18/2015 | Bfi Co., Llc | Major Shareholder | Sell | 6,000 | $37.76 | $226,560.00 | | |
| 8/17/2015 | Bfi Co., Llc | Major Shareholder | Sell | 6,000 | $36.76 | $220,560.00 | | |
| 7/24/2015 | Jack Bendheim | CEO | Sell | 18,000 | $37.98 | $683,640.00 | | |
| 7/21/2015 | Gerald K Carlson | COO | Sell | 8,000 | $37.97 | $303,760.00 | | |
| 7/20/2015 | Gerald K Carlson | COO | Sell | 8,000 | $38.16 | $305,280.00 | | |
| 7/15/2015 | Bfi Co., Llc | Major Shareholder | Sell | 18,000 | $38.13 | $686,340.00 | | |
| 7/15/2015 | Jack Bendheim | CEO | Sell | 6,000 | $37.75 | $226,500.00 | | |
| 7/14/2015 | Jack Bendheim | CEO | Sell | 6,000 | $38.25 | $229,500.00 | | |
| 7/13/2015 | Jack Bendheim | CEO | Sell | 6,000 | $38.41 | $230,460.00 | | |
| 7/9/2015 | Jack Bendheim | CEO | Sell | 18,000 | $36.90 | $664,200.00 | | |
| 7/2/2015 | Bfi Co., Llc | Major Shareholder | Sell | 19,000 | $38.02 | $722,380.00 | | |
| 6/26/2015 | Jack Bendheim | CEO | Sell | 36,000 | $36.37 | $1,309,320.00 | | |
| 6/23/2015 | Gerald K Carlson | COO | Sell | 16,000 | $36.56 | $584,960.00 | | |
| 6/22/2015 | Gerald K Carlson | COO | Sell | 8,000 | $36.47 | $291,760.00 | | |
| 6/17/2015 | Bfi Co., Llc | Major Shareholder | Sell | 4,000 | $34.09 | $136,360.00 | | |
| 6/17/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.13 | $397,560.00 | | |
| 6/16/2015 | Bfi Co., Llc | Major Shareholder | Sell | 4,000 | $33.00 | $132,000.00 | | |
| 6/15/2015 | Bfi Co., Llc | Major Shareholder | Sell | 4,000 | $32.31 | $129,240.00 | | |
| 6/11/2015 | Jack Bendheim | CEO | Sell | 12,000 | $32.38 | $388,560.00 | | |
| 6/4/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.68 | $404,160.00 | | |
| 5/28/2015 | Bfi Co., Llc | Major Shareholder | Sell | 18,000 | $35.11 | $631,980.00 | | |
| 5/21/2015 | Gerald K Carlson | COO | Sell | 16,000 | $35.62 | $569,920.00 | | |
| 5/19/2015 | Bfi Co., Llc | Major Shareholder | Sell | 18,000 | $36.73 | $661,140.00 | | |
| 5/18/2015 | Thomas G Dagger | SVP | Sell | 4,000 | $36.48 | $145,920.00 | | |
| 12/19/2014 | Daniel A Welch | SVP | Sell | 4,000 | $29.20 | $116,800.00 | | |
| 8/1/2014 | Bfi Co., Llc | Major Shareholder | Sell | 223,075 | $20.51 | $4,575,268.25 | | |
| 4/22/2014 | E Thomas Corcoran | Director | Buy | 5,000 | $16.70 | $83,500.00 | | |
| 4/16/2014 | Carol Wrenn | Director | Buy | 1,000 | $16.19 | $16,190.00 | | |
| 4/16/2014 | L.P. Mayflower | Major Shareholder | Sell | 6,323,867 | $13.99 | $88,470,899.33 | | |
(Data available from 1/1/2013 forward)
Phibro Animal Health (NASDAQ PAHC) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2018 Health Care Conference
finance.yahoo.com - April 20 at 9:24 AM |
 | Head to Head Comparison: Phibro Animal Health (PAHC) vs. RXi Pharmaceuticals (RXII)
www.americanbankingnews.com - April 18 at 7:14 PM |
| Phibro Animal Health (PAHC) Upgraded at BidaskClub
www.americanbankingnews.com - April 18 at 9:51 AM |
| Brokerages Anticipate Phibro Animal Health (PAHC) to Post $0.44 Earnings Per Share
www.americanbankingnews.com - April 17 at 5:19 PM |
| Phibro Animal Health Corp (PAHC) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - April 12 at 1:33 AM |
| Zacks Investment Research Downgrades Phibro Animal Health (PAHC) to Hold
www.americanbankingnews.com - April 11 at 9:52 AM |
| Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2018 Quarterly Financial Results
finance.yahoo.com - April 3 at 4:41 PM |
| Phibro Animal Health (PAHC) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 1 at 9:41 AM |
| Phibro Animal Health Corp (PAHC) Expected to Post Earnings of $0.44 Per Share
www.americanbankingnews.com - March 31 at 5:26 PM |
| 5 Stocks Near 52-Week High: Is More Upside Left?
finance.yahoo.com - March 28 at 9:29 AM |
 | Here's Why Phibro Animal Health is Worth a Buy Right Now
www.msn.com - March 20 at 4:32 PM |
| Here's Why Phibro Animal Health is Worth a Buy Right Now
finance.yahoo.com - March 20 at 4:32 PM |
| Contrasting Phibro Animal Health (PAHC) & Its Competitors
www.americanbankingnews.com - March 18 at 9:28 AM |
| Phibro Animal Health Corp (PAHC) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - March 18 at 1:36 AM |
| Bfi Co., Llc Sells 12,000 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - March 16 at 7:52 PM |
| Phibro Animal Health Corp (PAHC) Insider Jack Bendheim Sells 24,000 Shares
www.americanbankingnews.com - March 16 at 7:33 PM |
| Daniel M. Bendheim Sells 13,162 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - March 12 at 10:28 PM |
| Daniel M. Bendheim Sells 6,576 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - March 12 at 10:26 PM |
| Insider Selling: Phibro Animal Health Corp (PAHC) VP Sells 3,960 Shares of Stock
www.americanbankingnews.com - March 8 at 12:31 AM |
| Insider Selling: Phibro Animal Health Corp (PAHC) Major Shareholder Sells 12,000 Shares of Stock
www.americanbankingnews.com - March 8 at 12:30 AM |
| Phibro Animal Health Corp (PAHC) Major Shareholder Bfi Co., Llc Sells 12,000 Shares
www.americanbankingnews.com - March 8 at 12:30 AM |
| Jack Bendheim Sells 36,000 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - March 8 at 12:12 AM |
| Phibro Animal Health (PAHC) Up 7% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 7 at 5:29 PM |
| Phibro Animal Health (PAHC) Upgraded to "Sell" by BidaskClub
www.americanbankingnews.com - March 3 at 5:48 PM |
| Spark Investment Management LLC Increases Position in Phibro Animal Health Corp (PAHC)
www.americanbankingnews.com - March 3 at 12:36 PM |
| Is Phibro Animal Health Corporation (NASDAQ:PAHC) A Sell At Its Current PE Ratio?
finance.yahoo.com - March 2 at 9:08 AM |
| Phibro Animal Health Corp (PAHC) Insider Jack Bendheim Sells 36,000 Shares
www.americanbankingnews.com - March 2 at 12:16 AM |
| Jack Bendheim Sells 12,000 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - March 2 at 12:16 AM |
| Phibro Animal Health (PAHC) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - February 28 at 10:16 PM |
| Free Research Report as Phibro Animal Health’s Sales Jumped7%; Adjusted EPS Advanced 12.8%
finance.yahoo.com - February 28 at 9:10 AM |
| Phibro Animal Health Corp (PAHC) Shares Bought by American Century Companies Inc.
www.americanbankingnews.com - February 27 at 4:06 AM |
| Bfi Co., Llc Sells 14,802 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - February 27 at 12:12 AM |
| Jack Bendheim Sells 2,802 Shares of Phibro Animal Health Corp (PAHC) Stock
www.americanbankingnews.com - February 27 at 12:12 AM |
| Fuller & Thaler Asset Management Inc. Has $8.16 Million Position in Phibro Animal Health Corp (PAHC)
www.americanbankingnews.com - February 26 at 3:06 PM |
| $0.43 EPS Expected for Phibro Animal Health Corp (PAHC) This Quarter
www.americanbankingnews.com - February 25 at 3:12 PM |
| Phibro Animal Health Corp (PAHC) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - February 21 at 1:28 AM |
| Phibro Animal Health Corp (PAHC) Insider Sells $356,200.00 in Stock
www.americanbankingnews.com - February 14 at 12:16 AM |
| Insider Selling: Phibro Animal Health Corp (PAHC) COO Sells 14,182 Shares of Stock
www.americanbankingnews.com - February 14 at 12:16 AM |
| Insider Selling: Phibro Animal Health Corp (PAHC) COO Sells 54,572 Shares of Stock
www.americanbankingnews.com - February 14 at 12:16 AM |
| Phibro Animal Health Corp (PAHC) Forecasted to Earn FY2020 Earnings of $2.00 Per Share
www.americanbankingnews.com - February 9 at 5:50 PM |
| $0.41 Earnings Per Share Expected for Phibro Animal Health Corp (PAHC) This Quarter
www.americanbankingnews.com - February 8 at 11:14 PM |
| Phibro Animal Health (PAHC) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - February 8 at 3:50 PM |
| Phibro Animal Health Corp (PAHC) to Post FY2018 Earnings of $1.70 Per Share, Gabelli Forecasts
www.americanbankingnews.com - February 8 at 12:50 PM |
| Phibro Animal Health (PAHC) PT Raised to $36.00 at Morgan Stanley
www.americanbankingnews.com - February 7 at 12:44 PM |
| Phibro Animal Health Corp Plans Quarterly Dividend of $0.10 (PAHC)
www.americanbankingnews.com - February 6 at 5:22 PM |
| Phibro Animal Health Corporation Reports Second Quarter and Updated Annual Financial Guidance
finance.yahoo.com - February 6 at 4:17 PM |
 | Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2018 Animal Health Summit
feeds.benzinga.com - February 6 at 3:15 PM |
| Credit Suisse Group Increases Phibro Animal Health (PAHC) Price Target to $39.00
www.americanbankingnews.com - February 6 at 10:40 AM |
 | Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield
www.streetinsider.com - February 6 at 9:16 AM |
 | Phibro beats 2Q profit forecasts
www.cnbc.com - February 6 at 9:16 AM |
Phibro Animal Health (NASDAQ:PAHC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Phibro Animal Health (NASDAQ:PAHC) Income Statement, Balance Sheet and Cash Flow Statement
Phibro Animal Health (NASDAQ PAHC) Stock Chart for Monday, April, 23, 2018
Loading chart…
